Angiotensin I-Converting Enzyme Substrate
CAS No. 69677-91-4
Angiotensin I-Converting Enzyme Substrate( ——— )
Catalog No. M39858 CAS No. 69677-91-4
Angiotensin I-Converting Enzyme Substrate
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAngiotensin I-Converting Enzyme Substrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAngiotensin I-Converting Enzyme Substrate
-
DescriptionAngiotensin I-Converting Enzyme Substrate
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number69677-91-4
-
Formula Weight437.49
-
Molecular FormulaC24H27N3O5
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tau-aggregation and ...
Tau-aggregation and neuroinflammation-IN-1 is a potent inhibitor of tau protein aggregates, showing significant inhibitory activity against AcPHF6 and full-length tau protein aggregates.
-
CDK2
CDK2 is a member of the eukaryotic S/T protein kinase family and its function is to catalyze the phosphoryl transfer of ATP γ-phosphate to serine or threonine hydroxyl (denoted as S0/T0) in a protein substrate.
-
Omalizumab
Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).
Cart
sales@molnova.com